PharVision Advisers’s Ondas Inc ONDS Stock Holding History

PharVision Advisers’s Portfolio ONDS Stock Details ONDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18,641	Closed	-$182K	–	487
2025 Q4	$182K	Buy	+18,641	New	+$150K	0.09%	588

Other funds holding ONDS

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Defiance ETFs New York $6.98B AUM

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PharVision Advisers's ONDS Position: Q1 2026 in Review

PharVision Advisers sold out of Ondas Inc (ONDS) in Q1 2026, closing a stake of 18,641 shares — an estimated $182K sold.

PharVision Advisers first reported a position in ONDS in Q4 2025 and held it in 1 quarter. The position peaked at $182K in Q4 2025. 366 funds tracked by Wall St. Rank hold ONDS as of Q1 2026.

PharVision Advisers reported no remaining Ondas Inc position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 18,641 Ondas Inc shares in Q1 2026, an estimated $182K.
PharVision Advisers first reported a position in Ondas Inc in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Ondas Inc position peaked at $182K in Q4 2025.
366 funds tracked by Wall St. Rank held Ondas Inc as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.